Biomedical Sciences Program, University of Science and Technology, Zewail City of Science and Technology, Giza, Egypt.
Department of Food Hygiene and Technology and Institute of Food Science and Technology, Universidad de León, León, Spain.
PLoS One. 2021 Jun 24;16(6):e0253797. doi: 10.1371/journal.pone.0253797. eCollection 2021.
Campylobacter species are one of the most common causative agents of gastroenteritis worldwide. Resistance against quinolone and macrolide antimicrobials, the most commonly used therapeutic options, poses a serious risk for campylobacteriosis treatment. Owing to whole genome sequencing advancements for rapid detection of antimicrobial resistance mechanisms, phenotypic and genotypic resistance trends along the "farm-to-fork" continuum can be determined. Here, we examined the resistance trends in 111 Campylobacter isolates (90 C. jejuni and 21 C. coli) recovered from clinical samples, commercial broiler carcasses and dairy products in Cairo, Egypt. Multidrug resistance (MDR) was observed in 10% of the isolates, mostly from C. coli. The prevalence of MDR was the highest in isolates collected from broiler carcasses (13.3%), followed by clinical isolates (10.5%), and finally isolates from dairy products (4%). The highest proportion of antimicrobial resistance in both species was against quinolones (ciprofloxacin and/or nalidixic acid) (68.4%), followed by tetracycline (51.3%), then erythromycin (12.6%) and aminoglycosides (streptomycin and/or gentamicin) (5.4%). Similar resistance rates were observed for quinolones, tetracycline, and erythromycin among isolates recovered from broiler carcasses and clinical samples highlighting the contribution of food of animal sources to human illness. Significant associations between phenotypic resistance and putative gene mutations was observed, with a high prevalence of the gyrA T86I substitution among quinolone resistant isolates, tet(O), tet(W), and tet(32) among tetracycline resistant isolates, and 23S rRNA A2075G and A2074T mutations among erythromycin resistant isolates. Emergence of resistance was attributed to the dissemination of resistance genes among various lineages, with the dominance of distinctive clones. For example, sub-lineages of CC828 in C. coli and CC21 in C. jejuni and the genetically related clonal complexes 'CC206 and CC48' and 'CC464, CC353, CC354, CC574', respectively, propagated across different niches sharing semi-homogenous resistance patterns.
弯曲菌属是世界范围内最常见的胃肠炎致病菌之一。对喹诺酮类和大环内酯类抗菌药物的耐药性是弯曲菌病治疗的严重威胁,而这些药物是最常用的治疗选择。由于全基因组测序技术的进步,可快速检测到抗菌药物耐药机制,因此可以确定从“农场到餐桌”连续体中表型和基因型耐药趋势。在这里,我们研究了从埃及开罗的临床样本、商业肉鸡胴体和乳制品中分离出的 111 株弯曲菌(90 株空肠弯曲菌和 21 株大肠弯曲菌)的耐药趋势。10%的分离株表现出多药耐药性(MDR),主要来自大肠弯曲菌。在从肉鸡胴体中分离出的分离株中,MDR 的发生率最高(13.3%),其次是临床分离株(10.5%),最后是从乳制品中分离出的分离株(4%)。两种细菌对抗喹诺酮类药物(环丙沙星和/或萘啶酸)(68.4%)的耐药率最高,其次是四环素(51.3%),然后是红霉素(12.6%)和氨基糖苷类(链霉素和/或庆大霉素)(5.4%)。从肉鸡胴体和临床样本中分离出的分离株对喹诺酮类、四环素和红霉素的耐药率相似,这突出了动物源性食品对人类疾病的贡献。表型耐药与假定基因突变之间存在显著相关性,喹诺酮类耐药分离株中 gyrA T86I 取代的高流行率,四环素耐药分离株中 tet(O)、tet(W)和 tet(32),红霉素耐药分离株中 23S rRNA A2075G 和 A2074T 突变。耐药性的出现归因于各种谱系之间耐药基因的传播,具有独特克隆的优势。例如,大肠弯曲菌中的 CC828 亚谱系和空肠弯曲菌中的 CC21 以及遗传上相关的克隆复合体'CC206 和 CC48'和'CC464、CC353、CC354、CC574',分别在不同的生态位中传播,具有半同源的耐药模式。